Product Name:3-(2-bromo-7-oxo-4,5-dihydrothieno[2,3-c]pyridin-6-yl)piperidine-2,6-dione

IUPAC Name:3-{2-bromo-7-oxo-4H,5H,6H,7H-thieno[2,3-c]pyridin-6-yl}piperidine-2,6-dione

CAS:2970213-45-5
Molecular Formula:C12H11BrN2O3S
Purity:97%
Catalog Number:CM1076101
Molecular Weight:343.2

Packing Unit Available Stock Price($) Quantity
CM1076101-100mg in stock źǯƄ
CM1076101-250mg in stock Ŕźǯ
CM1076101-500mg in stock ȎźŔź
CM1076101-1g in stock ưŢŔŢ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2970213-45-5
Molecular Formula:C12H11BrN2O3S
Melting Point:-
Smiles Code:BrC1=CC2=C(S1)C(=O)N(CC2)C1CCC(=O)NC1=O
Density:
Catalog Number:CM1076101
Molecular Weight:343.2
Boiling Point:
MDL No:
Storage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products